REQUEST A DEMO
Total
USD $0.00
Search more companies

Imunomedica, A.S. (Czech Republic)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Imunomedica, A.S. Profile Updated: November 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Imunomedica, A.S. is an enterprise in Czech Republic, with the main office in Usti nad Labem. It operates in the Pharmaceutical Preparation Manufacturing industry. Imunomedica, A.S. was incorporated on October 01, 1996. Imunomedica, A.S. currently employs 25 - 49 (2023) people. In 2023, the company reported a net sales revenue increase of 46.4%. Its’ total assets recorded a growth of 23.36%. The net profit margin of Imunomedica, A.S. increased by 10.72% in 2023.

Headquarters
Veslarska 118
Usti nad Labem; Ustecky; Postal Code: 40331

Contact Details: Purchase the Imunomedica, A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Imunomedica, A.S. report to view the information.
Outstanding Shares:
Purchase the Imunomedica, A.S. report to view the information.
Registered Capital:
Purchase the Imunomedica, A.S. report to view the information.
Incorporation Date:
October 01, 1996
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
Vice Chairman of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Company Performance
Financial values in the chart are available after Imunomedica, A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
46.4%
Total operating revenue
46.33%
Operating profit (EBIT)
92.2%
EBITDA
78.33%
Net Profit (Loss) for the Period
93.57%
Total assets
23.36%
Total equity
14.2%
Operating Profit Margin (ROS)
13.05%
Net Profit Margin
10.72%
Return on Equity (ROE)
10.38%
Quick Ratio
-12.02%
Cash Ratio
-8.77%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?